The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a “Drug Alert” recalling certain batches of Novartis Consumer Health UK Ltd’s Tixylix cough and cold medicines from consumers.
The move is as a result of Novartis Consumer Health Ltd being made aware of a possible fault in the manufacturing process of the tamper seal that might result in small pieces of plastic being found in the liquid medicines.
There is currently no evidence of people having problems as a result of this manufacturing fault but they are being asked to return the following medicines as a precautionary measure.
Specific batches of the Tixylix medicines below are being recalled by Novartis:
:: Tixylix Toddler Syrup 100ml (Glycerol) PL 00030/0150
:: Tixylix Toddler Syrup 150ml (Glycerol) PL 00030/0150
:: Tixylix Baby Syrup 100ml (Glycerol) PL 00030/0150
:: Tixylix Blackcurrant Flavour Syrup 100ml (Glycerol) PL 00030/0150
:: Tixylix Chesty Cough 100ml (Guaifenesin) PL 00030/0082
Adam Burgess, the MHRA’s Head of Defective Medicines Reporting Centre (DMRC), said the recall was “precautionary” and there was currently no evidence that people had any problems with these medicines.
He asked anyone who had bought Tixylix to check the batch number on the bottle label next to the expiry date to see if it was one of the batches being recalled.
He added: “If anyone has an affected batch they should return it to the place of purchase for a refund. If people do have any questions they can contact Novartis on 0800 854 100 or visit the Tixylix website.”
Tags:
